胰腺体积对急性胰腺炎患者死亡率的影响评估
该单中心回顾性观察性队列研究纳入2015年1月至2020年12月共143例急性胰腺炎患者,利用计算机生成3D成像测量胰腺体积,并与CTSI、mCTSI评分比较对死亡率的预测价值。胰腺体积预测死亡的截断值为>81.5 cm³(OR 17.43,95%CI 2.2-138.1),AUC 0.787(95%CI 0.711-0.851)。CTSI的AUC为0.822(95%CI 0.750-0.881),mCTSI的AUC为0.955(95%CI 0.907-0.983),均优于胰腺体积。作者指出CTSI评分胰腺增大、mCTSI评分胰腺坏死和炎症,但两者均未明确对胰腺体积评分。
要点
- 胰腺体积>81.5 cm³预测死亡的OR为17.43(95%CI 2.2-138.1),敏感性92.3%、特异性60.0%、阳性预测值18.8%、阴性预测值98.7%。
- 胰腺体积预测死亡的AUC为0.787(95%CI 0.711-0.851),低于CTSI的0.822(95%CI 0.750-0.881)和mCTSI的0.955(95%CI 0.907-0.983)。
- CTSI评分胰腺增大、mCTSI评分胰腺坏死和炎症,但两者均未明确对胰腺体积进行评分。
- 该研究为单中心回顾性观察性队列,纳入143例急性胰腺炎患者,女性57.34%、男性42.66%。
适用人群与场景
- 2015年1月至2020年12月单中心收治的急性胰腺炎患者,通过ICD-9编码577.0或ICD-10编码K85.0从医院自动化系统获取,共143例。
诊断标准与关键阈值
- 胰腺体积预测死亡的截断值为>81.5 cm³。
研究设计与关键结果
- 研究类型:单中心回顾性观察性队列研究,纳入143例急性胰腺炎患者,女性57.34%、男性42.66%。
- 胰腺体积(计算机生成3D成像测量)预测死亡的截断值>81.5 cm³,OR 17.43(95%CI 2.2-138.1),Cohen's d 1.126,敏感性92.3%、特异性60.0%、阳性预测值18.8%、阴性预测值98.7%。
- 胰腺体积预测死亡的ROC分析AUC为0.787(95%CI 0.711-0.851)。
- CTSI预测死亡的AUC为0.822(95%CI 0.750-0.881),mCTSI预测死亡的AUC为0.955(95%CI 0.907-0.983)。
证据类型、等级与局限
- 证据类型:单中心回顾性观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在该研究人群中胰腺体积>81.5 cm³与死亡率升高相关。
- 作者指出,CTSI评分胰腺增大、mCTSI评分胰腺坏死和炎症,但两者均未明确对胰腺体积评分;CTSI和mCTSI预测死亡率均优于胰腺体积。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Pancreatic volume is enlarged in acute pancreatitis.
OBJECTIVE: This study aimed to evaluate whether there was a difference in pancreatic volume between survivors and non-survivors with acute pancreatitis using computer-generated 3D imaging.
METHOD: This single-center retrospective observational cohort study was conducted between January 2015 and December 2020. The hospital automation system was used to get the patients diagnosed with acute pancreatitis by using International Classification of Diseases (ICD) (ninth edition, code 577.0 or 10th version, code K 85.0) codes. The patients' pancreatic volumes, computed tomography severity index (CTSI), and modified computed tomography severity index (mCTSI) scores were calculated using the data obtained from the hospital automation system. The pancreatic volumes of the patients were measured using the computer-generated 3D imaging method. Pancreatic volume, CTSI, and mCTSI were then statistically compared in terms of mortality prediction by using the receiver operating characteristic (ROC) analysis.
RESULTS: Of the 143 patients, 57.34% were female and 42.66% were male. The cut-off value of pancreatic volume in determining mortality was>81.5 cm3 OR:17.43 (%95 CI: 2.2-138.1) Cohen's d:1.126, at which it had 92.3% sensitivity, 60.0% specificity, 18.8% positive predictive value, and 98.7% negative predictive value. As a result of the ROC analysis of pancreatic volume in mortality prediction, the area under curve (AUC) value was determined as 0.787 [95% confidence interval (CI): 0.711-0.851]. The ROC analysis of the CTSI and mCTSI scores in mortality prediction revealed AUC values of 0.822 (95%CI: 0.750-0.881) and 0.955 (95%CI: 0.907-0.983) respectively.
CONCLUSION: Although CTSI scores pancreatic enlargement and mCTSI scores pancreatic necrosis and inflammation, the pancreatic volume value is not clearly scored in both. In this study population, pancreatic volume above 81.5 cm was associated with increased mortality. Both CTSI and mCTSI scores outperformed pancreatic volume in predicting mortality.
参考来源
- Hökenek UD, Aydıner Ö, Kart JS, et al. Evaluation of the effect of pancreatic volume on mortality in patients with acute pancreatitis. Am J Emerg Med. 2022. PMID: 36327747. doi:10.1016/j.ajem.2022.10.032
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。